Robert Cozens

5.3k total citations
29 papers, 1.8k citations indexed

About

Robert Cozens is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Robert Cozens has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Robert Cozens's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Robert Cozens is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Robert Cozens collaborates with scholars based in Switzerland, United States and United Kingdom. Robert Cozens's co-authors include Elaine Tuomanen, W. TOSCH, Alexander Tomasz, O. Zák, Josef Brueggen, Peter R. Allegrini, Paul M.J. McSheehy, Éric Doelker, Robert Gurny and Bruno Galli and has published in prestigious journals such as Blood, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Robert Cozens

28 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Cozens Switzerland 18 955 338 260 229 212 29 1.8k
Gary Woodnutt United States 21 1.1k 1.1× 174 0.5× 188 0.7× 217 0.9× 237 1.1× 45 1.9k
Malika Kumarasiri United States 24 850 0.9× 370 1.1× 349 1.3× 160 0.7× 204 1.0× 34 1.9k
Nicola G. Wallis United Kingdom 23 908 1.0× 249 0.7× 162 0.6× 180 0.8× 198 0.9× 45 1.8k
Michael Hunter United Kingdom 24 850 0.9× 242 0.7× 98 0.4× 193 0.8× 128 0.6× 51 2.6k
Pan F. Chan United Kingdom 23 1.3k 1.4× 148 0.4× 317 1.2× 300 1.3× 515 2.4× 42 2.1k
D H Ho United States 27 887 0.9× 768 2.3× 273 1.1× 90 0.4× 317 1.5× 100 2.5k
Nancy J. Phillips United States 30 1.1k 1.2× 304 0.9× 135 0.5× 382 1.7× 164 0.8× 75 2.4k
Masaki Hirota Japan 17 806 0.8× 181 0.5× 83 0.3× 83 0.4× 104 0.5× 101 1.6k
Neeraj Chauhan United States 23 830 0.9× 243 0.7× 357 1.4× 71 0.3× 222 1.0× 69 1.8k
Anita R. Mistry United Kingdom 17 702 0.7× 248 0.7× 384 1.5× 184 0.8× 170 0.8× 20 1.6k

Countries citing papers authored by Robert Cozens

Since Specialization
Citations

This map shows the geographic impact of Robert Cozens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Cozens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Cozens more than expected).

Fields of papers citing papers by Robert Cozens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Cozens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Cozens. The network helps show where Robert Cozens may publish in the future.

Co-authorship network of co-authors of Robert Cozens

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Cozens. A scholar is included among the top collaborators of Robert Cozens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Cozens. Robert Cozens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ebel, Nicolas, Vincent Romanet, Rita Andraos, et al.. (2013). JAK1/2 and Pan-Deacetylase Inhibitor Combination Therapy Yields Improved Efficacy in Preclinical Mouse Models of JAK2V617F-Driven Disease. Clinical Cancer Research. 19(22). 6230–6241. 59 indexed citations
2.
Schnell, Christian, et al.. (2013). Abstract 3370: Use of fine needle aspirate biopsy (FNAB) in evaluating drug responses in tumor models: Better data with less animal use? .. Cancer Research. 73(8_Supplement). 3370–3370. 1 indexed citations
3.
Schnell, Christian, Stéphanie Barbé, Giorgio Caravatti, et al.. (2012). Abstract 3743: NVP-BYL719, a selective inhibitor of the class Ia PI3K isoform alpha impairs angiogenesis and microvascular permeability.. Cancer Research. 72(8_Supplement). 3743–3743.
4.
Manley, Paul W., Sandra W. Cowan‐Jacob, Robert Cozens, et al.. (2011). Fingolimod (FTY720) Inhibits BCR-ABL Signaling Allosterically by Binding to the Myristate Binding Site. Blood. 118(21). 2746–2746. 1 indexed citations
5.
Schnell, Christian, Frédéric Stauffer, Peter R. Allegrini, et al.. (2008). Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging. Cancer Research. 68(16). 6598–6607. 143 indexed citations
6.
Jensen, Michael Rugaard, Joseph Schoepfer, Thomas Radimerski, et al.. (2008). NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models. Breast Cancer Research. 10(2). R33–R33. 189 indexed citations
7.
8.
Traxler, Peter, Peter R. Allegrini, Ralf Brandt, et al.. (2004). AEE788. Cancer Research. 64(14). 4931–4941. 268 indexed citations
9.
Jaeghere, Fanny De, Éric Allémann, F. Kubel, et al.. (2000). Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. Journal of Controlled Release. 68(2). 291–298. 75 indexed citations
10.
Leroux, Jean-Christophe, Robert Cozens, Johannes Roesel, et al.. (1996). pH-Sensitive Nanoparticles: An Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitors in Dogs. Pharmaceutical Research. 13(3). 485–487. 49 indexed citations
11.
Fässler, Alexander, Guido Bold, Hans‐Georg Capraro, et al.. (1996). Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability. Journal of Medicinal Chemistry. 39(16). 3203–3216. 54 indexed citations
12.
Capraro, Hans‐Georg, Guido Bold, Alexander Fässler, et al.. (1996). Synthesis of Potent and Orally Active HIV‐Protease Inhibitors. Archiv der Pharmazie. 329(6). 273–278. 6 indexed citations
13.
Leroux, Jean-Christophe, Robert Cozens, Johannes Roesel, et al.. (1995). Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to Mice. Journal of Pharmaceutical Sciences. 84(12). 1387–1391. 60 indexed citations
14.
Gangemi, J. David, Robert Cozens, Erik De Clercq, Jan Balzarini, & H. K. Hochkeppel. (1989). 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections. Antimicrobial Agents and Chemotherapy. 33(11). 1864–1868. 66 indexed citations
15.
Cozens, Robert, Z Markiewicz, & Elaine Tuomanen. (1989). Role of autolysins in the activities of imipenem and CGP 31608, a novel penem, against slowly growing bacteria. Antimicrobial Agents and Chemotherapy. 33(10). 1819–1821. 20 indexed citations
16.
Zák, O., Marc Lang, Robert Cozens, et al.. (1988). Penems: In Vitro and In Vivo Experiments. The Journal of Clinical Pharmacology. 28(2). 128–135. 5 indexed citations
17.
Tuomanen, Elaine & Robert Cozens. (1987). Changes in peptidoglycan composition and penicillin-binding proteins in slowly growing Escherichia coli. Journal of Bacteriology. 169(11). 5308–5310. 47 indexed citations
18.
Cozens, Robert, et al.. (1986). Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrobial Agents and Chemotherapy. 29(5). 797–802. 129 indexed citations
19.
Cozens, Robert, et al.. (1983). Influence of Nutrient Limitation of Growth on Stability and Production of Virulence Factors of Mucoid and Nonmucoid Strains of Pseudomonas aeruginosa. Clinical Infectious Diseases. 5(Supplement_5). S880–S888. 40 indexed citations
20.
Gilbert, P., et al.. (1979). Influence of Suspending Media upon the Susceptibility of Pseudomonas aeruginosa NCTC 6750 and Its Spheroplasts to Polymyxin B. Antimicrobial Agents and Chemotherapy. 15(2). 147–151. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary Woodnutt Breakdown of academic impact, for papers by Malika Kumarasiri Breakdown of academic impact, for papers by Nicola G. Wallis Breakdown of academic impact, for papers by Michael Hunter Breakdown of academic impact, for papers by Pan F. Chan Breakdown of academic impact, for papers by D H Ho Breakdown of academic impact, for papers by Nancy J. Phillips Breakdown of academic impact, for papers by Masaki Hirota Breakdown of academic impact, for papers by Neeraj Chauhan Breakdown of academic impact, for papers by Anita R. Mistry
Rankless by CCL
2026